Andlauer Healthcare Group Inc. (ANDHF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Andlauer Healthcare Group Inc. (ANDHF) trades at $38.11 with AI Score 45/100 (Grade C). Andlauer Healthcare Group Inc. provides specialized third-party logistics and transportation solutions for the healthcare sector across Canada and the United States. Market cap: $1.49B, Sector: Industrials.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for ANDHF: ANDHF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ANDHF against Industrials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
ANDHF: the 1 perspectives are evenly split.
How is this calculated? →Andlauer Healthcare Group Inc. (ANDHF) Industrial Operations Profile
Andlauer Healthcare Group Inc. is a Canadian-based supply chain management company specializing in third-party logistics and transportation for the North American healthcare sector. It provides critical temperature-controlled and specialized distribution services for pharmaceuticals, medical devices, and other health products, leveraging a technology-enabled platform to serve manufacturers and distributors.
What Is the Investment Thesis for ANDHF?
Andlauer Healthcare Group Inc. presents a focused investment profile within the specialized healthcare logistics sector, driven by the stable and growing demand for pharmaceutical and medical device supply chain solutions in North America. The company's unique positioning as a provider of temperature-controlled and technology-enabled 3PL services for a wide array of healthcare products underpins its operational value. With a market capitalization of $1.49B and a profit margin of 10.4%, Andlauer demonstrates its ability to generate earnings from its specialized operations. Its gross margin of 22.8% reflects efficiency in delivering complex logistics services. The company's beta of 0.87 suggests relatively lower volatility compared to the broader market, which may appeal to investors seeking stability. Key growth catalysts include the increasing complexity of pharmaceutical products, such as biologics and vaccines, which necessitate stringent temperature control and specialized handling expertise. Expansion within the larger U.S. market, building on its established Canadian presence, offers substantial revenue growth potential. Furthermore, continuous investment in advanced supply chain technologies can enhance efficiency and service offerings, solidifying its competitive advantage. However, investors should note the company's P/E ratio of 42.0, indicating a potentially higher valuation. Operating on the OTC Other tier also introduces considerations regarding liquidity and disclosure, which require careful assessment.
Based on FMP financials and quantitative analysis
ANDHF Key Highlights
- Market capitalization stands at $1.49 billion, reflecting the company's overall market value.
- The P/E ratio of 42.0 indicates a higher valuation multiple relative to its earnings, suggesting investor expectations for future growth.
- A profit margin of 10.4% demonstrates the company's ability to convert revenue into net income efficiently within its specialized operations.
- Gross margin of 22.8% highlights the profitability of its core service offerings before operating expenses.
- A Beta of 0.87 suggests the stock exhibits lower volatility compared to the broader market, potentially appealing to risk-averse investors.
Who Are ANDHF's Competitors?
ANDHF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| FMMFF Fuji Corporation | $50.34 | +0.00% | $4.43B | 52 |
| CRGO Freightos Ltd. | $1.29 | +0.00% | $66.67M | 62 |
| INPOY InPost S.A. | $8.70 | -2.30% | $8.69B | 60 |
| PGUUF Prosegur Cash, S.A. | $0.72 | +0.00% | $1.05B | 56 |
| FDX FedEx Corporation | $309.49 | -1.12% | $73.85B | 56 |
| OSTIY Österreichische Post AG | $19.00 | +4.97% | $2.57B | 45 |
| KHNGF Kuehne + Nagel International AG | $238.22 | -4.09% | $28.29B | 45 |
| CDNIF Logista Integral, S.A. | $36.75 | +7.55% | $4.86B | 45 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ANDHF's Key Strengths?
- Specialized focus on the healthcare logistics sector, addressing critical and regulated needs.
- Comprehensive service offering, including temperature-controlled transport, warehousing, and packaging.
- Established presence and operational reach across both Canada and the United States.
- Leverages technology-enabled supply chain solutions for efficiency and client integration.
- Operates in a sector characterized by stable and growing demand for specialized services.
What Are ANDHF's Weaknesses?
- Trades on the OTC Other tier, which can lead to lower liquidity and wider bid-ask spreads.
- Disclosure status is unknown, potentially limiting investor access to comprehensive financial information.
- High P/E ratio of 42.0, suggesting a premium valuation that may imply higher growth expectations.
- Operates as a subsidiary, which might imply less independent strategic flexibility compared to a standalone entity.
What Could Drive ANDHF Stock Higher?
- Stable demand for specialized healthcare logistics services, driven by an aging population and increasing complexity of medical products.
- Expansion of specialized services for complex biologics and vaccines, which require stringent temperature control and handling expertise.
- Potential for strategic partnerships or acquisitions to expand geographic reach or enhance service offerings in North America.
- Further integration of advanced supply chain technologies to enhance operational efficiency, tracking capabilities, and client satisfaction.
What Are the Key Risks for ANDHF?
- Rich valuation — a P/E of 42.0 runs well above the Industrials sector’s ~30x, leaving little room for a miss.
- Operating in the OTC Other tier, which can present significant liquidity and regulatory risks for investors.
- Intense competition within the integrated freight and logistics sector, particularly for specialized healthcare services.
- Regulatory changes in the healthcare or transportation sectors in Canada and the United States, potentially increasing compliance costs.
- Economic downturns impacting overall healthcare spending or causing disruptions in global supply chains.
- Reliance on a specialized niche, making the company susceptible to shifts in healthcare product demand or logistics requirements.
What Are the Growth Opportunities for ANDHF?
- **Expanding Specialized Logistics for Biologics and Vaccines**: The global market for biologics and vaccines is experiencing robust growth, driven by advancements in biotechnology and increasing public health needs. These products often require ultra-cold storage and precise temperature control throughout the supply chain, a core competency of Andlauer Healthcare Group. By further investing in specialized infrastructure and expertise for these highly sensitive products, the company can capture a larger share of this high-value segment. The market for biopharmaceutical logistics is projected to continue expanding significantly over the next decade, offering a substantial long-term growth runway for specialized providers.
- **Deepening Penetration in the United States Market**: While Andlauer Healthcare Group has a presence in both Canada and the United States, the U.S. market represents a significantly larger and more diverse healthcare logistics opportunity. Expanding its operational footprint, client base, and service density within key U.S. regions could unlock substantial revenue growth. This involves leveraging existing capabilities and potentially strategic partnerships or acquisitions to enhance market access and service delivery. The vast scale of the U.S. pharmaceutical and medical device market provides ample room for specialized logistics providers to grow their market share over the medium to long term.
- **Enhancing Technology-Enabled Supply Chain Solutions**: The integration of advanced technologies such as AI-driven route optimization, real-time tracking, predictive analytics for inventory management, and blockchain for supply chain transparency can significantly enhance efficiency, reduce costs, and improve service reliability. Andlauer's existing "technology-enabled supply chain solutions" platform provides a foundation for further innovation. Investing in these areas can strengthen its competitive advantage, attract new clients seeking cutting-edge logistics, and optimize operational performance. This ongoing technological evolution is a continuous growth driver, with benefits realized over short to medium-term horizons.
- **Diversification into Adjacent Healthcare Product Categories**: Beyond traditional pharmaceuticals and medical devices, the healthcare sector includes rapidly growing segments like natural health products, animal health, and specialized consumer health aids. Andlauer's existing infrastructure and expertise in handling regulated products can be leveraged to expand into these adjacent categories. This diversification can broaden the company's revenue streams, reduce reliance on any single product type, and tap into new market opportunities. The market for these specialized health products is expanding, offering incremental growth potential over the medium term.
- **Strategic Acquisitions and Partnerships**: The fragmented nature of the logistics industry, particularly in specialized niches, presents opportunities for strategic consolidation. Andlauer Healthcare Group could pursue targeted acquisitions of smaller, specialized logistics firms to expand its geographic reach, acquire new technological capabilities, or deepen its expertise in specific healthcare sub-sectors. Similarly, forming strategic partnerships with complementary service providers could extend its network and service offerings without direct acquisition. These initiatives can accelerate growth, enhance market share, and create synergies, with impacts potentially realized in the short to medium term.
What Opportunities Does ANDHF Have?
- Expanding specialized logistics services for the growing biologics and vaccine markets.
- Deepening market penetration and expanding operational footprint within the larger U.S. healthcare market.
- Further integration and innovation of advanced supply chain technologies to enhance service and efficiency.
- Diversification into adjacent healthcare product categories such as natural health or animal health.
- Strategic acquisitions or partnerships to consolidate market share or expand service capabilities.
What Threats Does ANDHF Face?
- Potential for increased regulatory scrutiny or changes in healthcare and transportation regulations.
- Intense competition from other specialized logistics providers and larger general freight companies.
- Economic downturns that could impact healthcare spending or disrupt global supply chains.
- Risks associated with the OTC market, including potential for price volatility and limited investor interest.
- Operational challenges related to maintaining stringent temperature control and security for sensitive products.
What Are ANDHF's Competitive Advantages?
- Deep specialization in the highly regulated and complex healthcare logistics sector, requiring specific expertise and infrastructure.
- Extensive network and advanced infrastructure for temperature-controlled transportation and warehousing, critical for sensitive healthcare products.
- Proprietary technology-enabled supply chain solutions that enhance efficiency, tracking, and compliance for clients.
- Long-standing relationships and established trust with a diverse client base of healthcare manufacturers and distributors.
- Comprehensive, end-to-end service offering, from initial warehousing and packaging to last-mile delivery, simplifying client supply chains.
What Does ANDHF Do?
Andlauer Healthcare Group Inc., founded in Vaughan, Canada, in 1991, has evolved into a pivotal supply chain management company dedicated to the highly specialized healthcare sector across Canada and the United States. Operating as a subsidiary of Andlauer Management Group Inc., the company distinguishes itself by providing a robust platform of customized third-party logistics (3PL) and specialized transportation solutions. Its operations are strategically divided into two core segments: Specialized Transportation and Healthcare Logistics, ensuring a comprehensive approach to the complex demands of medical supply chains. The company's service portfolio is extensive, encompassing critical logistics and distribution services. This includes seamless client and customer integration, meticulous transportation and inventory management, efficient distribution and fulfillment, and secure warehousing solutions. Recognizing the unique requirements of healthcare products, Andlauer Healthcare Group also offers specialized packaging services such as co-packing, re-packing, assembly, and custom work, tailored to product specifications and regulatory compliance. A cornerstone of its offering is temperature-controlled services, essential for the integrity of sensitive pharmaceuticals, vaccines, and biologics. Beyond ground transport, the company provides air freight forwarding, dedicated delivery services, and last-mile solutions, ensuring timely and secure delivery. Its ground transportation capabilities include less-than-truckload (LTL), pick-up and delivery, and courier services, supported by various carrier options to optimize efficiency. Andlauer Healthcare Group serves a diverse client base, including healthcare manufacturers, wholesalers, distributors, and other 3PL providers. The breadth of products handled is significant, ranging from pharmaceuticals, vaccines, biologics, narcotics, and active pharmaceutical ingredients to over-the-counter medications, cosmetics, health and beauty aids, and medical devices, as well as natural, animal, and consumer health products. This broad expertise, coupled with a platform of technology-enabled supply chain solutions, positions Andlauer Healthcare Group as a critical enabler for the North American healthcare industry, ensuring the safe and efficient movement of vital products.
What Products and Services Does ANDHF Offer?
- Provide customized third-party logistics (3PL) for the healthcare sector.
- Offer specialized transportation solutions, including temperature-controlled services for sensitive products.
- Manage client and customer integration for complex healthcare supply chains.
- Handle comprehensive transportation and inventory management services.
- Provide distribution, fulfillment, and warehousing solutions for healthcare products.
- Offer specialized packaging services such as co-packing, re-packing, assembly, and custom work.
- Deliver air freight forwarding, dedicated last-mile delivery, and ground transportation services.
- Transport a wide range of healthcare products including pharmaceuticals, vaccines, medical devices, and biologics across North America.
How Does ANDHF Make Money?
- Generates revenue by charging fees for specialized transportation services, encompassing ground, air freight, and dedicated delivery options.
- Earns income from third-party logistics (3PL) services, including warehousing, distribution, and fulfillment solutions tailored for healthcare clients.
- Derives revenue from value-added services such as temperature-controlled storage, specialized packaging, and custom assembly work.
- Provides integrated supply chain management platforms and technology-enabled solutions to healthcare manufacturers, wholesalers, and distributors for a fee.
What Industry Does ANDHF Operate In?
Andlauer Healthcare Group Inc. operates within the highly specialized and regulated Integrated Freight & Logistics industry, specifically targeting the healthcare sector in North America. This segment is characterized by stringent compliance requirements, the need for advanced infrastructure like temperature-controlled warehousing and transportation, and robust security protocols for sensitive products such as pharmaceuticals, vaccines, and medical devices. The broader market trend indicates a growing demand for outsourced logistics services within healthcare, driven by increasing product complexity, global supply chains, and the need for cost efficiency. Companies like Andlauer are positioned to capitalize on this trend by offering tailored, end-to-end solutions. The competitive landscape includes specialized logistics providers and larger general freight companies with dedicated healthcare divisions. Fuji Corporation (FMMFF) is identified as a peer, highlighting the presence of other specialized players. Andlauer's focus on a comprehensive, technology-enabled platform for diverse healthcare products allows it to carve out a distinct niche within this essential industry.
Who Are ANDHF's Key Customers?
- Healthcare manufacturers, including pharmaceutical and biotechnology companies.
- Wholesalers and distributors of medical products and supplies.
- Other third-party logistics (3PL) providers seeking specialized healthcare capabilities.
- Companies involved in medical devices, over-the-counter products, cosmetics, and consumer health aids.
FY2026 estForward Outlook
Wall Street analysts project Andlauer Healthcare Group Inc. revenue of about $708.7M for fiscal 2026, with EPS near $2.07.
Quarterly Financial Performance: Andlauer Healthcare Group Inc.
Revenue for Andlauer Healthcare Group Inc. came in at $156.6M during Q2 2025, a 5.7% contraction versus the preceding quarter. The company recorded net income of $13.4M, with diluted EPS of $0.34. Revenue has contracted over three consecutive quarters, which investors in this small-cap Industrials stock should monitor closely. Across the four most recent quarters, ANDHF averaged $0.42 in diluted EPS.
ANDHF Valuation & Market Position
With a $1.49B market cap, Andlauer Healthcare Group Inc. sits in the small-cap segment of the market. Relative to its peer group, ANDHF's quantitative score of 45/100 is below the peer average of 57/100.
ROE 12%Key Financial Metrics
Return on equity for Andlauer Healthcare Group Inc. stands at 11.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 7.4%, showing how much profit it generates from its asset base. ANDHF trades at a trailing price-to-earnings ratio of 42.03, above the Industrials sector average of ~30x. Its free cash flow yield is 3.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.35 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.4%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 7/9Financial Health
Andlauer Healthcare Group Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 7.08 places it in the safe zone, indicating low near-term bankruptcy risk.
Company Profile
Andlauer Healthcare Group Inc. operates in the Integrated Freight & Logistics industry within the Industrials sector. It is headquartered in Vaughan, CA. The company is led by CEO Michael N. Andlauer. ANDHF has traded publicly since 2020.
ANDHF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future prospects.
- Community sentiment indicates growing optimism about Andlauer's strategic direction.
- The market increasingly views Andlauer as a stable player in a growing sector.
- Positive community discussions highlight Andlauer's strong relationships with key healthcare providers.
Bear Case
- Some insiders may be selling shares to diversify their portfolios, not necessarily indicating a lack of faith in the company.
- A segment of the community expresses concern over increased competition in the healthcare logistics space.
- Market perception might be overly optimistic, potentially leading to a price correction.
- Negative community feedback points to potential challenges in integrating recent acquisitions.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2025 | $157M | $13M | $0.34 |
| Q1 2025 | $166M | $20M | $0.51 |
| Q4 2024 | $168M | $18M | $0.44 |
| Q3 2024 | $160M | $16M | $0.41 |
Based on FMP financials and quantitative analysis
ANDHF Latest News
No recent news available for ANDHF.
ANDHF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ANDHF.
Price Targets
Wall Street price target analysis for ANDHF.
ANDHF MoonshotScore
What does this score mean?
The MoonshotScore rates ANDHF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Michael N. Andlauer
Chief Executive Officer
Michael N. Andlauer serves as the Chief Executive Officer of Andlauer Healthcare Group Inc., overseeing the strategic direction and operational management of the company's 2,380 employees. While specific details regarding his educational background, prior career history, and previous roles before leading Andlauer Healthcare Group are not provided in the available data, his leadership is central to the company's operations within the specialized healthcare logistics sector. His role involves steering the company's efforts in providing customized third-party logistics and transportation solutions across North America, focusing on the unique demands of pharmaceuticals, medical devices, and other health-related products.
Track Record: Under Michael N. Andlauer's leadership, Andlauer Healthcare Group Inc. has established itself as a significant player in specialized healthcare logistics in Canada and the United States. His management has guided the company in developing a comprehensive platform of temperature-controlled and technology-enabled supply chain solutions. The company's sustained operations since its founding in 1991, with a current employee base of 2,380, reflect a track record of operational stability and growth within its niche market.
ANDHF OTC Market Information
Andlauer Healthcare Group Inc. trades on the OTC market under the "OTC Other" tier. This classification signifies that the company does not meet the listing requirements for major exchanges like the NYSE or NASDAQ, nor does it qualify for higher OTC tiers like OTCQX or OTCQB, which have more stringent financial and disclosure standards. Companies in the "OTC Other" tier typically have limited public disclosure, often relying on a "Pink Current Information" or "Pink No Information" status, though Andlauer's disclosure status is "Unknown." This tier generally implies less transparency and oversight compared to exchange-listed or higher-tier OTC securities.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity and wider bid-ask spreads due to OTC Other tier trading, making it difficult to execute trades efficiently.
- "Unknown" disclosure status, which implies a lack of readily available financial and operational information for investor due diligence.
- Increased price volatility due to lower trading volumes and fewer market participants.
- Potential for less regulatory oversight compared to exchange-listed securities, which could expose investors to greater risks.
- Difficulty in obtaining reliable valuation metrics and analyst coverage due to the OTC listing and disclosure level.
- Verify the company's current financial statements and annual reports directly from official sources if available.
- Research any known regulatory filings or public announcements made by the company.
- Assess the company's business operations, market position, and competitive landscape independently.
- Investigate the management team's background, experience, and track record beyond what is publicly stated.
- Understand the specific risks associated with the "OTC Other" tier, including liquidity and disclosure limitations.
- Evaluate the company's ownership structure, particularly its subsidiary relationship with Andlauer Management Group Inc.
- Seek independent legal and financial advice regarding investing in OTC securities with unknown disclosure.
- Established founding year in 1991, indicating a long operational history.
- Specialization in a critical and regulated sector (healthcare logistics).
- Significant employee base of 2,380, suggesting a substantial operational scale.
- Clear business description of providing complex supply chain solutions across North America.
- Identified as a subsidiary of Andlauer Management Group Inc., implying a broader corporate structure.
Andlauer Healthcare Group Inc. Industrials Stock: Key Questions Answered
What does Andlauer Healthcare Group Inc. do?
Andlauer Healthcare Group Inc. is a specialized supply chain management company providing third-party logistics (3PL) and transportation solutions exclusively for the healthcare sector in Canada and the United States. The company offers a comprehensive suite of services, including warehousing, distribution, inventory management, and specialized packaging. A key differentiator is its expertise in temperature-controlled logistics, essential for sensitive products like pharmaceuticals, vaccines, and biologics. It also provides air freight, dedicated last-mile delivery, and ground transportation services, serving healthcare manufacturers, wholesalers, and distributors with technology-enabled solutions for a wide array of health-related products.
How does Andlauer Healthcare Group Inc. compare to competitors in its industry?
Andlauer Healthcare Group Inc. distinguishes itself through its deep specialization in healthcare logistics, a highly regulated and demanding niche. While specific direct comparisons to all competitors are not provided, its listed peer, Fuji Corporation (FMMFF), also operates within the broader industrials sector, potentially offering similar logistics or manufacturing support. Andlauer's competitive advantage lies in its comprehensive, temperature-controlled supply chain platform tailored for sensitive healthcare products across North America. This specialization, coupled with its technology-enabled solutions and extensive service offerings from warehousing to last-mile delivery, allows it to serve a critical market segment that requires precise and compliant logistics solutions, differentiating it from general freight and logistics providers.
What are the key financial metrics investors watch for ANDHF?
For Andlauer Healthcare Group Inc., investors typically monitor several key financial metrics to assess its performance and valuation within the specialized logistics sector. The P/E ratio of 42.0 is a crucial valuation metric, indicating how much investors are willing to pay for each dollar of earnings, often reflecting growth expectations or specialized market positioning. Profit Margin (10.4%) and Gross Margin (22.8%) are vital for understanding the company's operational efficiency and profitability in delivering its complex services. Additionally, the Beta of 0.87 provides insight into the stock's volatility relative to the broader market, suggesting a potentially more stable investment. The Dividend Yield of 0.44% indicates the return to shareholders from dividends.
What are the main risks for ANDHF, especially as an OTC stock?
Andlauer Healthcare Group Inc. faces several risks, particularly due to its operation in a specialized sector and its OTC listing. As an OTC Other tier stock, ANDHF is subject to significant liquidity risks, meaning lower trading volumes and wider bid-ask spreads can make it challenging to buy or sell shares efficiently. The "Unknown" disclosure status further compounds this, limiting access to critical financial and operational information for comprehensive due diligence. Beyond OTC-specific concerns, the company operates in a competitive integrated freight and logistics industry, facing potential pressure from larger players or new entrants. Regulatory changes in the healthcare or transportation sectors in Canada and the U.S. could also impact operations and compliance costs.
What are the key factors to evaluate for ANDHF?
Andlauer Healthcare Group Inc. (ANDHF) holds an AI score of 45/100 (low). P/E: 42.0x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does ANDHF data refresh on this page?
ANDHF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven ANDHF's recent stock price performance?
Andlauer Healthcare Group Inc. (ANDHF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized focus on the healthcare logistics sector, addressing critical and regulated needs. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ANDHF overvalued or undervalued right now?
Andlauer Healthcare Group Inc. (ANDHF) trades at 42.0x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based solely on provided source data.
- CEO background and track record details are limited in source data.
- Disclosure status for OTC is unknown as per source.